<?xml version="1.0" encoding="UTF-8"?>
<p>This lineage was established in 1982 from a human hepatocellular carcinoma; it is therefore able to produce a great variety of substances secreted by the human liver (
 <xref rid="B58" ref-type="bibr">58</xref>) and has been used in the study of hepatitis C virus, SARS-CoV, and MERS-CoV (
 <xref rid="B27" ref-type="bibr">27</xref>, 
 <xref rid="B34" ref-type="bibr">34</xref>, 
 <xref rid="B58" ref-type="bibr">58</xref>, 
 <xref rid="B59" ref-type="bibr">59</xref>). In the context of SARS-CoV-2, this cell line has been used in the study of infection mechanisms (
 <xref rid="B23" ref-type="bibr">23</xref>, 
 <xref rid="B39" ref-type="bibr">39</xref>), the cytotoxicity of viruses from human hosts (
 <xref rid="B22" ref-type="bibr">22</xref>, 
 <xref rid="B60" ref-type="bibr">60</xref>), and in pharmacological research (
 <xref rid="B26" ref-type="bibr">26</xref>, 
 <xref rid="B46" ref-type="bibr">46</xref>, 
 <xref rid="B48" ref-type="bibr">48</xref>).
</p>
